Hydroquinone stimulates granulocyte-macrophage progenitor cells in vitro and in vivo

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1271-1274

  Henschler, R ^a   Glatt, H R ^b   Heyworth, C M ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Benzene; Bone marrow; Granulocyte macrophage colony forming cells; Granulocyte macrophage colony stimulating factor; Hydroquinone; Phenol

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROQUINONE; PHENOL;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE MARROW; CONFERENCE PAPER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0030472296     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041271     Document Type: Conference Paper

References (23)

1. Collegium Ramazzini. International Conference on Benzene. Am J Ind Med 7:361 (1985).
2. Laskin S, Goldstein BD. Benzene toxicity: a crirical review. J Toxicol Environ Health (Suppl 2):23-36 (1977).
3. Goldstein BD. Clinical hematotoxicity of benzene. Adv Mod Environ Toxicol 4:51 (1983).
4. Aksoy M. Benzene as a leukemogenic and carcinogenic agent. Am J Ind Med 4:589 (1985).
5. 3H-Benzene metabolism in rabbit bone marrow. Life Sci 25:567 (1979).
6. Rickert DE, Baker TS, Bus JS, Barrow CS, Irons RD. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol 49:417 (1979)
7. Sawahata T, Rickert DE, Greenlee WF. Metabolism of benzene and its metabolites in bone marrow. In: Toxicology of the Blood and Bone Marrow (Irons RD, ed). New York:Raven Press, 1985;141-158.
8. Greenlee WF, Sun JD, Bus JS. A proposed mechanism of benzene toxicity: formation of reactive intermediates from polyphenol metabolites. Toxicol Appl Pharmacol 59:187 (1981).
9. Witz G, Rao GS, Goldstein BD. Short-term toxicity of trans, trans-mucondialdehyde. Toxicol Appl Pharmacol 80:511 (1985).
10. Latriano L, Goldstein BD, Witz G. Formation of mucondi-aldehyde, an open-ring metabolite of benzene, in mouse liver microsomes: an additional pathway for toxic metabolites. Proc Natl Acad Sci USA 83:8356 (1986).
11. Dean BJ. Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat Res 154:153 (1985).
12. Glatt HR, Padykula R, Berchtold G, Ludewig G, Platt KL, Klein J, Oesch F. Multiple activation pathways of benzene leading to products with varying genotoxic characteristics. Environ Health Perspect 82:81 (1989).
13. Jowa L, Winkle S, Kalf G, Snyder R. Deoxyguanosine adducts formed from benzoquinone and hydroquinone. In: Biological Reactive Intermediates. III: Mechanism of Action in Animal Models and Human Disease (Kocsis JJ, Jollow DJ, Witmer CM, Nelson JO, Snyder R, eds). New York:Plenum Press, 1985;825.
14. Garnett H, Cronkhite EP, Drew RT. Effect of in vivo exposure to benzene on the characteristics of bone marrow adherent cells. Leuk Res 7:803 (1983).
15. Gaido K, Wierda D. Modulation of stromal cell function in DBA/2 and B6D2F1 mice exposed to benzene or phenol. Toxicol Appl Pharmacol 81:469 (1985).
16. Lewis JG, Odom B, Adams DO. Toxic effects of benzene and benzene metabolites on mononuclear phagocytes. Toxicol Appl Pharmacol 92:246 (1988).
17. Laskin DL, MacEachern L, Snyder R. Activation of bone marrow phagocytes following benzene treatment of mice. Environ Health Perspect 82:75 (1989).
18. King AG, Landreth KS, Wierda D. Hydroquinone inhibits bone marrow pre-B cell maturation in vitro. Mol Pharmacol 32:807 (1987).
19. Irons RD, Stillman WS, Colagiovanni DE, Henry VA. Synergistic interaction of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte-macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA 89:3691 (1992).
20. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol 91:85 (1987).
21. Spooncer E, Heyworth CM. Colony assays of murine haemopoietic cells. In: Haemopoiesis - A Practical Approach (Molineux G, Tests NG, eds). New York:Oxford University Press, 1992.
22. Spooncer E, Heyworth CM, Dunn A, Dexter TM. Self-renewal and differentiation of interleukin-3 dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 31:111 (1986).
23. Karasuyama H, Melchers F. Establishment of mouse cell lines which secrete large quantities of interleukin 2,3,4 or 5, using modified cDNA expression vectors. Eur J Immunol 18:97 (1988).